Smead Value Fund Sells 16.6% of American Express Stake at $361.63
Smead Value Fund reduced its American Express holding by 16.6% in Q1, selling 110,622 shares at an average price of $361.63 per share. American Express stock has declined 12.89% over three months and 14.64% year-to-date.
1. Large Stake Reduction in American Express
Smead Value Fund trimmed 110,622 American Express shares in the first quarter of 2026, representing a 16.6% cut and accounting for 0.97% of the fund’s portfolio. The shares were sold at an average price of $361.63, reflecting the fund’s shift away from this financial services position.
2. AXP Recent Stock Performance
American Express shares have fallen 12.89% over the past three months and are down 14.64% year-to-date, underscoring the rationale for the fund’s reduction amid weaker short-term returns.
3. Fund Portfolio Overview
As of Q1 2026, Smead Value Fund holds 27 stocks concentrated across eight sectors, with its largest positions in Simon Property Group (7.04%), Merck (6.78%), Cenovus Energy (6.11%), Amgen (6.00%) and APA Corp (5.58%).